Showing results (461-470 of 607) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|May 19, 2019
Use of Initial Noninvasive Cardiac Testing and Association with Downstream Healthcare Resource: A Retrospective Review of Resources Used Across a 12-Month Window for Probable Type I Myocardial Infarction PatientsDana Villines, Wm Thomas Summerfelt, James R Spalding, et al.
Pharmacoeconomics - Open|May 25, 2019
Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast TexasGabriela Orsak, Anastasia Miller, Carlton M Allen, et al.
Pharmacoeconomics - Open|May 11, 2019
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017Cara Usher, Laura McCullagh, Lesley Tilson, et al.
Pharmacoeconomics - Open|April 27, 2019
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UKClaire Telford, Evelina Bertranou, Samuel Large, et al.
Pharmacoeconomics - Open|October 4, 2021
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH StudyPedro Labisa, Valeska Andreozzi, Melina Mota, et al.
Pharmacoeconomics - Open|April 26, 2022
Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape AnalysisZachary Baldwin, Boshen Jiao, Anirban Basu, et al.
Pharmacoeconomics - Open|June 10, 2019
Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic ArthritisNatalie Boytsov, Xiang Zhang, Kristin A Evans, et al.
Pharmacoeconomics - Open|June 13, 2019
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in SwedenKorinna Karampampa, Hanna Gyllensten, Fei Yang, et al.
Pharmacoeconomics - Open|June 30, 2019
The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation ModelZhuo T Su, Jose Bartelt-Hofer, Stephen Brown, et al.
Pharmacoeconomics - Open|June 27, 2019
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNigel Fleeman, James Mahon, Sarah Nevitt, et al.
Pageof 61